证券代码：300797 证券简称：钢研纳克 公告编号：2023-022 钢研纳克检测技术股份有限公司 关于回购注销部分限制性股票暨通知债权人的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 钢研纳克检测技术股份有限公司（以下简称"公司"）分别于 2024 年 4 月 17 日召开了第 二届董事会第二十四次会议、第二届监事会第二十一次会议，审议通过了《关于回购注销< 钢研纳克检测技术股份有限公司首期限制性股票激励计划>部分限制性股票的议案》，鉴于 公司《首期限制性股票激励计划（草案修订稿）》（以下简称"《激励计划》"）预留授予激励 对象中 1 名激励对象因集团调动与公司解除劳动关系，公司拟将其已获授但尚未解除限售 的限制性股票共计 75,000 股（调整后）进行回购注销。2024 年 5 月 10 日上述相关议案已经 公司 2023 年年度股东大会审议通过。 本次回购注销完成后，公司总股本将由 383,175,000 股减少至 383,100,000 股（最终以本 次回购注销事项完成后中国证券登记结算有限公司深圳分公司出具的股本结构表为准），注 册资本相应 ...

北京海润天睿律师事务所 关于钢研纳克检测技术股份有限公司 2023 年度股东大会的法律意见书 致：钢研纳克检测技术股份有限公司 根据《中华人民共和国公司法》（以下简称《公司法》）、《中华人民共和国证 券法》（以下简称《证券法》）、《上市公司股东大会规则》（以下简称《股东大会 规则》）以及其他相关规章的规定，北京海润天睿律师事务所（以下称"本所"） 接受钢研纳克检测技术股份有限公司（以下简称"公司"）委托，指派本所邹盛武 律师、王士龙律师（以下称"本所律师"）出席公司 2023 年度股东大会，并就本 次股东大会的召集和召开程序、出席会议人员及会议召集人资格、审议事项以及 表决方式、表决程序、表决结果等相关事项依法进行见证。 经核查，本次股东大会现场会议按照股东大会通知如期于 2024 年 5 月 10 日下午 15:30 在北京市海淀区气象路 9 号钢研纳克检测技术股份有限公司新材料 大楼十层第一会议室召开，会议由董事长杨植岗先生主持。 本所律师认为，公司本次股东大会召开通知的时间、方式、通知内容符合《公 司法》《证券法》《股东大会规则》《公司章程》的要求，本次股东大会的召集和 召开程序符合法律、法规和规范性文 ...

证券代码：300797 证券简称：钢研纳克 公告编号：2024-020 钢研纳克检测技术股份有限公司 关于举行2023年度网上业绩说明会的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导 性陈述或重大遗漏。 钢研纳克检测技术股份有限公司（以下简称"公司"）已于2024年4月19日在巨潮资讯网 （http://www.cninfo.com.cn/）披露了公司2023年年度报告及其摘要，为便于广大投资者进一步了 解公司2023年年度报告和经营情况，公司定于2024年5月16日（星期四）15:00-17:00在深圳证券 交易所"互动易"平台"云访谈"栏目举办2023年度网上业绩说明会。本次业绩说明会将采用 网络远程的方式举行，投资者可登陆深圳证券交易所"互动易"平台"云访谈"栏目 （https://irm.cninfo.com.cn/views/interview）参与本次年度业绩说明会，进行互动与交流。 届时，出席本次年度网上业绩说明会的人员有：公司董事长杨植岗先生、总经理张秀鑫先 生、财务总监兼董事会秘书刘彬先生和独立董事夏宁先生。 为充分尊重投资者、提升交流的针对性，现就公司 ...

钢研纳克检测技术股份有限公司 证券代码：300797 证券简称：钢研纳克 公告编号：2024-017 关于第二届董事会第二十五次会议决议的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、董事会召开情况 钢研纳克检测技术股份有限公司（以下简称"公司"）第二届董事会第二十五次会议于 2024 年 4 月 24 日以通讯形式召开，会议通知于 2024 年 4 月 12 日以专人送出、电子邮件等 方式送达全体董事。 会议由公司董事长杨植岗先生主持，公司监事与高级管理人员列席了本次会议。本次会 议应出席董事人数 7 人，实际出席董事人数 7 人。出席董事资格、人数以及召集、召开程序 等均符合《中华人民共和国公司法》等法律法规和《钢研纳克检测技术股份有限公司章程》 的规定，本次会议合法有效。 二、董事会会议审议情况 经与会董事充分讨论，本次会议审议并通过了如下议案： 1、审议通过《关于<钢研纳克检测技术股份有限公司 2024 年第一季度报告>的议案》 本议案已经审计委员会审议通过。 经审议，董事会一致同意《钢研纳克检测技术股份有限公司 2024 年第一季度报告》 ...

证券代码：300797 证券简称：钢研纳克 公告编号：2024-018 钢研纳克检测技术股份有限公司 关于第二届监事会第二十二次会议决议的公告 钢研纳克检测技术股份有限公司（以下简称"公司"）第二届监事会第二十二次会议于 2024 年 4 月 24 日以通讯形式召开，会议通知于 2024 年 4 月 12 日以专人送出、电子邮件等 方式送达全体监事。 会议由公司监事会主席金戈女士主持。本次会议应出席监事人数 3 人，实际出席监事人 数 3 人。出席监事资格、人数以及召集、召开程序等均符合《中华人民共和国公司法》等法 律法规和《钢研纳克检测技术股份有限公司章程》的规定，本次会议合法有效。 二、监事会会议审议情况 经与会监事充分讨论，本次会议审议并通过了如下议案： 1、审议通过《关于<钢研纳克检测技术股份有限公司 2024 年第一季度报告>的议案》 经审议，监事会一致同意《钢研纳克检测技术股份有限公司 2024 年第一季度报告》。 监事会经过认真审议，认为董事会编制和审议钢研纳克检测技术股份有限公司 2024 年 第一季度报告的程序符合法律、行政法规和中国证监会的规定，报告内容真实、准确、完整 地反映了上市公司的 ...

证券代码：300797 证券简称：钢研纳克 公告编号：2024-016 1、被担保方名称：钢研纳克（沈阳）检测技术有限公司 钢研纳克检测技术股份有限公司 关于为控股子公司提供担保的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、担保情况概述 根据投资计划和资金需求，钢研纳克检测技术股份有限公司（以下简称"钢研纳克"） 控股子公司钢研纳克（沈阳）检测技术有限公司（以下简称"沈阳纳克"）拟向招商银行沈 阳分行申请 7,000 万元银行授信，控股股东钢研纳克按出资比例 52%提供 3,640 万元担保， 沈阳纳克对钢研纳克就此授信提供的担保提供反担保。 本次担保金额共计 3,640 万元，占最近一期经审计净资产的 3.46%，截至 2023 年末沈 阳纳克资产负债率 33.63%。本次担保经第二届董事会第二十五次会议审议通过。本次担保 无需提交股东大会或有关部门批准。 二、被担保人基本情况 2、统一社会信用代码：91210112MAC4R8AJ05 6、注册资本：15,000 万元人民币 10、最近一期相关财务数据： 单位：（万元） | | 2023 年度 ...

Financial Performance - The company's revenue for Q1 2024 was CNY 204,384,749.24, representing a 15.50% increase compared to CNY 176,961,219.88 in the same period last year[5] - Net profit attributable to shareholders was CNY 12,065,700.43, up 22.53% from CNY 9,847,337.32 year-on-year[5] - The basic earnings per share rose to CNY 0.0324, reflecting a 22.26% increase from CNY 0.0265 in the same quarter last year[5] - Net profit for Q1 2024 was ¥4,972,899.57, representing a 40.8% increase from ¥3,533,619.41 in Q1 2023[17] - Basic earnings per share for Q1 2024 were ¥0.0324, up from ¥0.0265 in Q1 2023, reflecting a growth of 22.3%[18] Cash Flow - The net cash flow from operating activities was negative CNY 134,059,923.42, a decline of 66.36% compared to negative CNY 80,585,200.94 in the previous year[5] - The company reported a significant increase of 965.61% in cash flow from financing activities, amounting to CNY 5,586,860.47, compared to negative CNY 645,425.58 in the previous year[9] - The cash inflow from financing activities was 7,027,780.75, with a net cash flow of 5,586,860.47, compared to -645,425.58 in the same period last year[21] - The total cash outflow from investment activities was 25,428,570.38, down 32.2% from 37,544,453.78 in the same period last year[21] - The company reported a total cash outflow of -154,050,037.96, compared to -118,768,000.22 in the previous year, reflecting a decline of approximately 29.7%[21] Assets and Liabilities - Total assets decreased by 3.83% to CNY 1,807,224,155.56 from CNY 1,879,143,520.60 at the end of the previous year[10] - Current assets total 895,527,331.64 yuan, down from 978,710,562.77 yuan[14] - The total liabilities decreased to ¥726,936,514.42 from ¥806,420,477.07, a reduction of 9.9% year-on-year[17] - Current liabilities decreased to 521,399,811.72 yuan from 596,969,173.29 yuan[14] Equity and Shareholder Information - The company's total equity attributable to shareholders increased by 1.39% to CNY 1,067,015,048.33 from CNY 1,052,357,649.86 at the end of the previous year[5] - The total equity attributable to shareholders of the parent company increased to ¥1,067,015,048.33, up from ¥1,052,357,649.86, marking a growth of 1.4%[17] - The largest shareholder, China Steel Research Technology Group, holds 64.38% of the shares, totaling 246,686,631 shares[11] - The total number of common shareholders at the end of the reporting period is 16,733[11] Expenses - Research and development expenses increased by 33.14% to CNY 27,853,783.60, driven by higher R&D costs at Jiangsu Nake[9] - The company reported a 19.06% increase in selling expenses, which reached CNY 31,076,915.78 compared to CNY 26,100,880.60 in the same period last year[9] - Total operating costs amounted to ¥211,093,550.44, up 16.0% from ¥182,117,924.39 year-on-year[16] - Research and development expenses increased to ¥27,853,783.60, a rise of 33.8% compared to ¥20,921,295.95 in the previous year[17] Other Information - The company has no preferred shareholders or related party transactions affecting the top shareholders[12] - The company reported a decrease in other comprehensive income, with a net amount of -¥49,770.40 compared to -¥9,230.57 in the previous year[18] - The company plans to continue investing in new technologies and market expansion strategies to drive future growth[17] - The company has not undergone an audit for the first quarter report[22]

钢研纳克检测技术股份有限公司 控股股东及其他关联方资金占用情况的 专项说明 大华核字[2024]0011001108 号 大 华 会 计 师 事 务 所 (特 殊 普 通 合 伙 ) Da Hua Certified Public Accountants（Special General Partnership） 钢研纳克检测技术股份有限公司 控股股东及其他关联方资金占用情况的专项说明 二、 钢研纳克检测技术股份有限公司 2023 年度非 经营性资金占用及其他关联资金往来情况汇 总表 1-3 （截止 2023 年 12 月 31 日） 目 录 页 次 一、 控股股东及其他关联方资金占用情况的专项 说明 1-2 大华会计师事务所（特殊普通合伙） 北京市海淀区西四环中路 16 号院 7 号楼 12 层 [100039] 电话：86 (10) 5835 0011 传真：86 (10) 5835 0006 www.dahua-cpa.com 控 股 股 东 及 其 他 关 联 方 资 金 占 用 情 况 的 专 项 说 明 大华核字[2024]0011001108 号 钢研纳克检测技术股份有限公司全体股东： 我们接受委 ...

Financial Performance - The company reported a significant increase in revenue, with a year-on-year growth of 15% in 2023[19]. - The net profit for the year reached 150 million CNY, representing a 20% increase compared to the previous year[19]. - The company's operating revenue for 2023 reached ¥949,532,672.96, representing a 16.45% increase compared to ¥815,419,867.85 in 2022[24]. - Net profit attributable to shareholders for 2023 was ¥125,697,377.39, a 10.41% increase from ¥113,842,380.06 in 2022[24]. - The total assets at the end of 2023 amounted to ¥1,879,143,520.60, reflecting a 12.66% increase from ¥1,667,923,982.82 at the end of 2022[24]. - The basic earnings per share for 2023 was ¥0.3350, a 9.55% increase from ¥0.3058 in 2022[24]. - The total revenue for 2023 reached CNY 949,532,672, representing a year-on-year increase of 46.86% compared to CNY 504,564,071 in 2022[79]. - The company reported a total revenue of 1,003 million RMB for the fiscal year 2023, reflecting a year-on-year increase of 10%[140]. - The net profit attributable to shareholders was 669 million RMB, representing a growth of 15% compared to the previous year[140]. Market Expansion and Growth Strategy - The company is focusing on expanding its market presence, targeting a 30% growth in new regions in 2024[19]. - Future guidance indicates an expected revenue growth of 18% for 2024, driven by increased demand in the testing sector[19]. - The company plans to expand its market presence by entering new regions, targeting a 20% increase in market share over the next two years[140]. - The company is expanding its market presence in Southeast Asia, targeting a 25% increase in market share within the next two years[146]. - The company is exploring potential mergers and acquisitions to strengthen its market position and expand its service capabilities[19]. - A strategic acquisition of a local competitor was announced, valued at 200 million RMB, aimed at consolidating market position[146]. Research and Development - The company has allocated 10 million CNY for research and development in new technologies for the upcoming year[19]. - The company authorized 56 patents and published 42 standards in 2023, with 22 of them being led in formulation or revision[61]. - Research and development expenses for 2023 were CNY 102,610,908.61, a slight increase of 1.26% from CNY 101,337,128.39 in 2022[85]. - The number of R&D personnel increased by 38.03% to 196 in 2023, with a higher proportion of staff holding master's degrees, rising by 66.67%[86]. - The company is developing several new technologies, including a high-precision measurement system for high-temperature irregular workpieces, expected to enhance economic benefits and core competitiveness[86]. - The company plans to launch three new products in the next fiscal year, which are expected to contribute an additional 5% to overall revenue[140]. - The company’s new product developments included high-end scientific instruments, with significant sales achievements in plasma mass spectrometers and scanning electron microscopes[72]. Operational Efficiency and Cost Management - The company plans to implement cost control measures and lean management to reduce expenses and improve efficiency[111]. - The company aims to reduce operational costs by 5% through efficiency improvements in the next fiscal year[146]. - The company has implemented a new operational strategy focusing on efficiency improvements, aiming to reduce operational costs by 5%[140]. - The company maintains a cost-plus pricing strategy for its services and products, ensuring profitability while considering market conditions and production costs[51]. Governance and Compliance - The company has established a governance structure that ensures clear responsibilities among the board, supervisory board, and management[130]. - The board consists of 7 members, including 3 independent directors, complying with legal requirements[132]. - The company has maintained independence from its controlling shareholder in terms of operations, personnel, assets, and finances[136]. - The company has implemented a "Quality Return Double Improvement" action plan[128]. - The company strictly adheres to information disclosure regulations, ensuring timely and accurate information for investors[135]. - The company has established specialized committees under the board, including an audit committee and a strategic committee, to enhance governance[132]. Employee Management and Development - The company reported a total of 1,288 employees at the end of the reporting period, with 679 in the parent company and 609 in major subsidiaries[165]. - The employee composition includes 622 production personnel, 229 sales personnel, 196 technical personnel, 30 financial personnel, and 211 administrative personnel[165]. - The company has a total of 34 PhD holders, 300 master's degree holders, 624 bachelor's degree holders, 204 associate degree holders, and 126 individuals with education below associate degree[165]. - The company conducts both internal and external training programs to enhance employee skills and safety awareness[168]. - The company has established a comprehensive salary management system, focusing on performance and market competitiveness[166]. Risks and Challenges - The management highlighted potential risks in the market, including regulatory changes and competition, which could impact future performance[5]. - The company faces intensified competition in the testing industry, with a low industry concentration and increasing pressure from international firms entering the market through various means, which could adversely affect its operational performance[117]. - The company acknowledges the risk of operational performance fluctuations due to external economic challenges and intensified market competition, and plans to enhance its core competitiveness to mitigate these risks[125]. - Continuous technological innovation is crucial; failure to keep pace with market demands may weaken the company's competitive advantage and affect its market share and performance[119]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of 1.00 CNY per 10 shares (including tax) based on a total of 383,175,000 shares[5]. - The proposed cash dividend is 1.00 CNY per 10 shares (before tax), totaling 38,317,500 CNY, which represents 30.48% of the net profit attributable to shareholders and 36.67% of the parent company's net profit[173]. - The company has a profit distribution plan that aligns with its articles of association and dividend management policies, ensuring compliance with regulations[171]. - The cash dividend distribution plan is designed to provide stable and reasonable returns to investors while considering the company's long-term development[173].

Financial Performance - The company reported a significant increase in revenue, with a year-on-year growth of 15% in 2023[19]. - The company's operating revenue for 2023 was CNY 949,532,672.96, representing a 16.45% increase compared to CNY 815,419,867.85 in 2022[24]. - The net profit attributable to shareholders for 2023 was CNY 125,697,377.39, a 10.41% increase from CNY 113,842,380.06 in 2022[24]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 103,127,521.28, up 27.87% from CNY 80,647,992.72 in 2022[24]. - The total assets at the end of 2023 were CNY 1,879,143,520.60, reflecting a 12.66% increase from CNY 1,667,923,982.82 at the end of 2022[24]. - The basic earnings per share for 2023 was CNY 0.3350, a 9.55% increase from CNY 0.3058 in 2022[24]. - The company reported a total revenue of 1,003 million RMB for the fiscal year 2023, reflecting a year-on-year increase of 10%[140]. - The company reported a total revenue of 3,997 million in 2022, an increase from 2,195 million in 2021, reflecting a growth of approximately 82.5%[101]. Dividend Policy - The company plans to distribute a cash dividend of 1.00 yuan (including tax) for every 10 shares based on a total of 383,175,000 shares[5]. - The proposed cash dividend is 1.00 CNY per 10 shares, totaling 38,317,500 CNY, which represents 30.48% of the net profit attributable to shareholders and 36.67% of the parent company's net profit[173]. - The company implemented a dividend policy, distributing 0.5 RMB per share to shareholders, reflecting a commitment to returning value to investors[140]. Market Expansion and Strategy - The company is focusing on expanding its market presence, particularly in the Asia-Pacific region, aiming for a 20% increase in market share by 2025[19]. - The company plans to expand its market presence in Southeast Asia, targeting a 25% increase in market share within the next two years[140]. - The company is expanding its market presence in Southeast Asia, targeting a 10% market share by 2025[146]. - A strategic acquisition of a local competitor is under consideration to enhance service capabilities and broaden the product portfolio[140]. - The company has completed a strategic acquisition of a local competitor for 300 million RMB to enhance its service capabilities[146]. Research and Development - The company has invested 10 million yuan in R&D for new product development, targeting the launch of two new testing technologies in 2024[19]. - The company authorized 56 patents and published 42 standards in 2023, demonstrating strong innovation capabilities[61]. - The company has allocated 100 million RMB for research and development in the upcoming year, focusing on advanced materials testing technologies[140]. - The company’s R&D expenses for 2023 were CNY 102,610,908.61, a slight increase of 1.26% compared to CNY 101,337,128.39 in 2022[85]. - The number of R&D personnel increased by 38.03% to 196 in 2023, with a higher proportion of personnel holding master's degrees[86]. - The company is developing several new technologies, including a high-precision measurement system for high-temperature irregular workpieces, expected to enhance economic benefits[86]. Customer Engagement and Satisfaction - User data indicates a 25% increase in customer engagement through digital platforms in 2023[19]. - The company is implementing new strategies to enhance customer satisfaction, aiming for a 90% satisfaction rate by the end of 2024[19]. - The number of users increased by 20% compared to the previous year, reaching a total of 500,000 active users[140]. - User data indicates an increase in active clients by 25%, reaching a total of 500,000 users[146]. Operational Efficiency - The company achieved a net profit margin of 12% in 2023, reflecting improved operational efficiency[19]. - The gross margin for third-party testing services was 50.63%, reflecting an increase of 2.38% compared to the previous year[78]. - The company maintains a cost-plus pricing strategy for its services and products, ensuring profitability while considering market conditions and production costs[51]. - The company’s financial expenses decreased significantly by 39.94% to CNY 3,218,435.12, indicating improved financial management[85]. Risk Management - The company has identified potential risks in its future operations, including regulatory changes and market competition, which are detailed in the management discussion section[5]. - The company recognizes risks related to brand reputation and social credibility, which are critical for its long-term sustainability[116]. - The company faces intensified competition in the testing industry, with many international firms entering the market, which could adversely affect its operating performance if it does not enhance technological and management innovation[117]. - The company is closely monitoring external economic conditions and is prepared to implement measures to enhance its core competitiveness in response to market fluctuations[125]. Governance and Management - The company has established a governance structure that ensures clear responsibilities among the board, supervisory board, and management[130]. - The board consists of 7 members, including 3 independent directors, complying with legal requirements[132]. - The company maintains independence from its controlling shareholder in terms of operations, assets, and finances[136]. - The company has a comprehensive remuneration decision-making process based on performance and responsibilities[153]. - The company has established a strong governance structure with independent directors overseeing operations[151]. Employee Development - The company emphasizes talent development to build a competitive workforce for sustainable growth[114]. - The company conducts both internal and external training programs to enhance employee skills and safety awareness[168]. - The employee composition includes 622 production personnel, 229 sales personnel, 196 technical personnel, 30 financial personnel, and 211 administrative personnel[165]. Compliance and Internal Control - The company established a comprehensive internal control system to ensure the authenticity and completeness of financial information, including the formulation of 10 internal audit regulations[199]. - The company has not reported any significant internal control deficiencies during the reporting period, indicating effective governance practices[200]. - The company adheres to strict information disclosure practices, ensuring timely and accurate information is available to all investors[135]. Future Projections - The company expects a revenue growth guidance of 15% for the next fiscal year, projecting revenues to reach approximately 1,153 million RMB[140]. - The company has projected a revenue growth of 20% for the next fiscal year, aiming for 1.44 billion RMB[146]. - The management team has set a goal to achieve a net profit margin of 12% by the end of 2024, up from 10% in 2023[146].